Edesa Biotech

-$0.03 (-0.63%) Today
+$0.18 (+3.78%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Edesa Biotech and other ETFs, options, and stocks.

About EDSA

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. The company product candidate, EB01 is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness.

CEO
Pardeep Nijhawan
Employees
12
Headquarters
Markham, Ontario
Founded
2007

EDSA Key Statistics

Market Cap
68.80M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
44.78K
High Today
$4.88
Low Today
$4.74
Open Price
$4.78
Volume
31.03K
52 Week High
$10.15
52 Week Low
$4.05

EDSA Earnings

-$0.26
-$0.17
-$0.09
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Aug 27, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure